Menu Search

Company Announcements

Latest announcements

Date and timeCompanyHeadlineSource
Capital Gearing Trust Plc - Net Asset Value(s)PR Newswire
Newgen Software reports Revenues from operations at Rs 1,244 cr in FY'24, up 28% YoY; Profit after Tax at Rs 252 cr, up 42% YoYPR Newswire
MASON RESOURCES UNDERSCORES BLACK SWAN GRAPHENE'S LAUNCH OF GRAPHENE-ENHANCED COMMERCIAL MASTERBATCHESPR Newswire
Aurora Improves Offerings in Australia with New Range of Premium Dried Flower ProductsCanada Newswire
MASON RESOURCES UNDERSCORES BLACK SWAN GRAPHENE'S LAUNCH OF GRAPHENE-ENHANCED COMMERCIAL MASTERBATCHESCanada Newswire
Aurora Improves Offerings in Australia with New Range of Premium Dried Flower ProductsPR Newswire
Mid Wynd International Investment Trust Plc - Net Asset Value(s)PR Newswire
Newgen Software reports Revenues from operations at Rs 1,244 cr in FY'24, up 28% YoY; Profit after Tax at Rs 252 cr, up 42% YoYPR Newswire
Newgen Software reports Revenues from operations at Rs 1,244 cr in FY'24, up 28% YoY; Profit after Tax at Rs 252 cr, up 42% YoYCanada Newswire
Corning Reports First-Quarter 2024 Financial ResultsBusiness Wire
Enanta Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Business Wire
BlackRock Frontiers Investment Trust Plc - Net Asset Value(s)PR Newswire
Hot Chili Secures Large Addition to its Costa Fuego Coastal Copper Hub in ChilePR Newswire
Hot Chili Secures Large Addition to its Costa Fuego Coastal Copper Hub in ChileCanada Newswire
BlackRock Throgmorton Trust Plc - Net Asset Value(s)PR Newswire
BlackRock Sustainable American Income Trust Plc - Net Asset Value(s)PR Newswire
Grown Rogue Completes Fiscal Year End Change, Reports Audited Financial Results for the Two Months Ending December 31, 2023Canada Newswire
Debiopharm & Repare Therapeutics Announce First Patient Dosed in Phase 1/1b Mythic Trial Evaluating the Synthetic Lethal Combination of WEE1 AND PKMYT1 InhibitionBusiness Wire
BlackRock Greater Europe Investment Trust Plc - Net Asset Value(s)PR Newswire
Repare Therapeutics & Debiopharm Announce First Patient Dosed in Phase 1/1b MYTHIC Trial Evaluating the Synthetic Lethal Combination of PKMYT1 and WEE1 InhibitionBusiness Wire
RNS announcements are delayed by up to an hour.
...